NewAmsterdam Pharma Company N.V. Stock BOERSE MUENCHEN
Equities
KH6
NL00150012L7
Biotechnology & Medical Research
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
17.4 EUR | 0.00% | 0.00% | 0.00% |
Sales 2024 * | 8.61M 9.37M 12.81M | Sales 2025 * | 6.3M 6.86M 9.37M | Capitalization | 1.56B 1.7B 2.33B |
---|---|---|---|---|---|
Net income 2024 * | -209M -228M -311M | Net income 2025 * | -139M -151M -207M | EV / Sales 2024 * | 182 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 248 x |
P/E ratio 2024 * |
-7.46
x | P/E ratio 2025 * |
-11.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.29% |
Latest transcript on NewAmsterdam Pharma Company N.V.
Current month | +1.75% | ||
1 month | -13.86% | ||
3 months | -20.91% |
Date | Price | Change |
---|---|---|
24-06-04 | 17.4 | 0.00% |
24-06-03 | 17.4 | +1.75% |
24-05-31 | 17.1 | -0.58% |
24-05-30 | 17.2 | -2.27% |
24-05-29 | 17.6 | -1.68% |
Real-time BOERSE MUENCHEN, June 04, 2024 at 03:43 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+0.61% | 22.48B | |
-9.63% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- NAMS Stock
- KH6 Stock